ASSESSMENT OF RILMENIDINE EFFICIENCY IN PATIENTS WITH ARTERIAL HYPERTENSION WITH DETERIORATION OF DAILY PROFILE OF BLOOD PRESSURE

<p><strong>Aim.</strong> To estimate an efficiency and tolerability of rilmenidine in hypertensive patients with different types of blood pressure (BP) daily profile - dipper and non-dipper.</p><p><strong>Methods.</strong> 23 patients with essential hyperten...

Full description

Saved in:
Bibliographic Details
Main Authors: P. P. Tikhonov (Author), L. A. Sokolova (Author)
Format: Book
Published: Столичная издательская компания, 2015-12-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_b95d843468be453685536e3cf671b51c
042 |a dc 
100 1 0 |a P. P. Tikhonov  |e author 
700 1 0 |a L. A. Sokolova  |e author 
245 0 0 |a ASSESSMENT OF RILMENIDINE EFFICIENCY IN PATIENTS WITH ARTERIAL HYPERTENSION WITH DETERIORATION OF DAILY PROFILE OF BLOOD PRESSURE 
260 |b Столичная издательская компания,   |c 2015-12-01T00:00:00Z. 
500 |a 1819-6446 
500 |a 2225-3653 
500 |a 10.1234/1819-6446-2005-2-14-19 
520 |a <p><strong>Aim.</strong> To estimate an efficiency and tolerability of rilmenidine in hypertensive patients with different types of blood pressure (BP) daily profile - dipper and non-dipper.</p><p><strong>Methods.</strong> 23 patients with essential hypertension (EH), I-II stages, were included into the study. They were treated with rilmeneidine 1 mg daily during one month. Ambulatory BP monitoring (ABPM) and office BP measurements were made before and after the treatment. Based on ABPM results all patients were divided into two groups: with adequate decrease of BP at nighttime (dipper, D), and with insufficient decrease of BP at nighttime (non-dipper, ND).</p><p><strong>Results.</strong> One month rilmenidine monotherapy resulted in BP normalization in 52% of patients. Decrease in 24-hour BP, daytime and nighttime BP, burden with BP and BP variability during daytime was observed in both groups. A distinction in rilmenidine influence on BP daily index was revealed: initially normal BP daily index didn't change in D group, while initially decreased BP daily index increased in ND group. Rilmenidine reduced the speed of morning BP rise in patients of ND group.</p><p><strong>Conclusion.</strong> Results of the study testify efficiency and satisfactory tolerability of monotherapy with rilmenidine 1 mg daily in patients with EH of I-II stages. For patients with insufficient decrease in BP during nighttime rilmenidine provides normalization of BP daily profile intensifying BP night decrease and reducing the speed of morning BP rise.</p> 
546 |a EN 
546 |a RU 
690 |a артериальная гипертензия 
690 |a суточный профиль АД 
690 |a рилменидин 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
690 |a Diseases of the circulatory (Cardiovascular) system 
690 |a RC666-701 
655 7 |a article  |2 local 
786 0 |n Рациональная фармакотерапия в кардиологии, Vol 1, Iss 2, Pp 14-19 (2015) 
787 0 |n http://www.rpcardio.ru/jour/article/view/348 
787 0 |n https://doaj.org/toc/1819-6446 
787 0 |n https://doaj.org/toc/2225-3653 
856 4 1 |u https://doaj.org/article/b95d843468be453685536e3cf671b51c  |z Connect to this object online.